Immunosuppressive effects of organic acids accumulating in patients with maple syrup urine disease.
Wajner
M
M
Department of Biochemistry, UFRGS, Porto Alegre, RS, Brazil.
Schlottfeldt
J L
JL
Ckless
K
K
Wannmacher
C M
CM
D002208:Caproates / Q000378:metabolism; D002478:Cells, Cultured; D045782:Hemiterpenes; D006801:Humans; D007651:Keto Acids / Q000378:metabolism*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008375:Maple Syrup Urine Disease / Q000276:immunology*; D008934:Mitogens / Q000494:pharmacology; D010421:Pentanoic Acids / Q000378:metabolism; D010835:Phytohemagglutinins / Q000494:pharmacology; D014631:Valerates / Q000378:metabolism
D002208:Caproates; D045782:Hemiterpenes; D007651:Keto Acids; D008934:Mitogens; D010421:Pentanoic Acids; D010835:Phytohemagglutinins; D014631:Valerates; C035864:2-hydroxyisovaleric acid; C016211:alpha-keto-beta-methylvaleric acid; C001505:alpha-ketoisovalerate; C013082:alpha-ketoisocaproic acid